A Marriage between AME Publishing Company and The World Society Of Emergency Surgery in academic cooperation

We are glad to announce that the World Society Of Emergency Surgery has entered into a strategic cooperation agreement with AME Publishing Company on Friday, February 24, 2017.

This cooperation could be regarded as a combination of the resource advantage of AME and WSES. According to Dr. Federico Coccolini, an active member of the board of WSES, WSES has been publishing guidelines since almost ten years, leading some of the main emergency and trauma surgery fields. 

Read More>>

Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven

Influence of waiting time (interval from end of preoperative therapy to surgery).

Read More>>

Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression

SMAD4 immunohistochemical studies (IHC) expression patterns in ampullary adenocarcinoma. (A) Diffuse (strong staining comparable to surrounding pancreas); (B) focal (two cell population with a subset of clearly negative cells) (100×); (C) trace (weak reactivity relative to surrounding pancreas); (D) absent (no staining). (A, C, D: 200×).

Read More>>

Percutaneous biliary drainage catheter insertion in patients with extensive hepatic metastatic tumor burden

A 57-year-old female with extensive hepatic metastases and hyperbilirubinemia.

Read More>>

Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study

Waterfall plot summarizing maximum observed radiographic response by response evaluation criteria in solid tumors criteria version 1.1 in the treated liver lobes (or segments).

Read More>>

Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma

Progression-free survival (PFS) and overall survival (OS) as stratified by positron emission tomography (PET) response.

Read More>>

Beyond RAS and BRAF: a target rich disease that is ripe for picking

Mitogen-activated protein kinase (MAPK) pathway and phosphoinositide 3 kinase (PI3K) pathway with downstream effectors.

Read More>>

Summary of emerging targets in anal cancer: the case for an immunotherapy based-approach

PD-L1 staining by immunohistochemistry in anal cancer. Using a monoclonal antibody against the PD-L1 antibody, diffuse cell surface staining of PD-L1 (brown) is observed on the surfaces of tumor cells from a resected SCCA specimen. PD, programmed death; SCCA, squamous cell carcinoma of the anal canal.

Read More>>

Testimonials for JGO from Eminent Experts Worldwide

Eminent experts, including editorial board members, authors and readers, who know the journal well, provided testimonials for JGO. We are thankful for their vigorous support for the journal.

Read More>>